Abstract Influences of adenosine 2A receptor (A 2A R) activity on the cardiac transcriptome and genesis of endotoxemic myocarditis are unclear. We applied transcriptomic profiling (39 K Affymetrix arrays) to identify A 2A R-sensitive molecules, revealed by receptor knockout (KO), in healthy and endotoxemic hearts. Baseline cardiac function was unaltered and only 37 A 2A R-sensitive genes modified by A 2A R KO (≥1.2-fold change, <5 % FDR); the five most induced are Mtr, Ppbp, Chac1, Ctsk and Cnpy2 and the five most repressed are Hp, Yipf4, Acta1, Cidec and Map3k2. Few canonical paths were impacted, with altered Gnb1, Prkar2b, Pde3b and Map3k2 (among others) implicating modified G protein/cAMP/PKA and cGMP/NOS signalling. Lipopolysaccharide (LPS; 20 mg/kg) challenge for 24 h modified >4100 transcripts in wild-type (WT) myocardium (≥1.5-fold change, FDR < 1 %); the most induced are Lcn2 (+590); Saa3 (+516); Serpina3n (+122); Cxcl9 (+101) and Cxcl1 (+89) and the most repressed are Car3 (−38); Adipoq (−17); Atgrl1/Aplnr (−14); H19 (−11) and Itga8 (−8). Canonical responses centred on inflammation, immunity, cell death and remodelling, with pronounced amplification of tolllike receptor (TLR) and underlying JAK-STAT, NFκB and MAPK pathways, and a 'cardio-depressant' profile encompassing suppressed ß-adrenergic, PKA and Ca 2+ signalling, electromechanical and mitochondrial function (and major shifts in transcripts impacting function/injury including Lcn2, S100a8/S100a9, Icam1/Vcam and Nox2 induction, and Adipoq, Igf1 and Aplnr repression). Endotoxemic responses were selectively modified by A 2A R KO, supporting inflammatory suppression via A 2A R sensitive shifts in regulators of NFκB and JAK-STAT signalling (IκBζ, IκBα, STAT1, CDKN1a and RRAS2) without impacting the cardio-depressant gene profile. Data indicate A 2A Rs exert minor effects in un-stressed myocardium and selectively suppress NFκB and JAK-STATsignalling and cardiac injury without influencing cardiac depression in endotoxemia.
Introduction
Uncontrolled inflammation with sepsis and the systemic inflammatory response syndrome induce multiple organ dysfunction, including cardiac abnormalities key to disease progression and mortality [1] . Unravelling the complex mechanisms governing Kevin 
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Electronic supplementary material The online version of this article (doi:10.1007/s11302-016-9536-1) contains supplementary material, which is available to authorized users. myocardial injury [1, 2] is not only fundamentally important but also reveals targets for manipulating outcomes. In this regard, adenosine 2A receptors (A 2A Rs) may fulfil a broadly suppressive role to limit inflammatory injury in multiple tissues [3] [4] [5] [6] and enhance myocardial resistance to ischaemic/hypoxic insult, presenting a potentially useful therapeutic target [3, 7] . In heart, this G protein-coupled receptor (GPCR) influences coronary tone and angiogenesis, cardiac contractility, fibroblast growth and fibrosis and may mediate protection via ischaemic pre-and postconditioning [8] [9] [10] . Inflammatory modulation contributes to this latter cardioprotection [9] [10] [11] , together with the regulation of myocyte kinase signals to limit oxidative stress, mitochondrial dysfunction and cell death [12] [13] [14] . However, impacts of the A 2A R on integrated myocardial responses to uncontrolled inflammation, and the mechanisms underlying such effects, remain to be elucidated.
While adenosine analogues and A 2A R agonists can limit endotoxemic or septic injury in lung [15, 16] , liver [17] , brain [18] and heart [19] [20] [21] , the roles of intrinsic A 2A R activity are less clear. Receptor deletion fails to modify inflammatory markers/injury in some studies [22] , reportedly worsens endotoxemic injury in heart [23] and lung [15, 24] and improves survival in models of polymicrobial sepsis [25, 26] . These divergent outcomes may reflect different cell-and organ-specific effects of A 2A Rs, for example promoting inflammasome formation and macrophage-dependent injury [27] , impairing bacterial clearance [25] , while activating cardiac survival signalling and suppressing inflammation [3, 7, [12] [13] [14] . Nonetheless, opposing effects of endogenous vs. exogenous (or amplified endogenous) adenosine are evident within cell types, for example inhibiting vs. promoting vascular myocyte NOS activation with inflammation [28] . The chronicity of receptor activation may also be critical to tissue-specific responses; while acute or transient increases in adenosine levels/receptor activity are generally beneficial (improving tissue perfusion, ischemic/hypoxic tolerance and reducing cytokines/inflammation), chronic elevations may be detrimental, exaggerating fibrotic processes via A 2B Rs in lung [29] or A 2A and A 2B Rs in liver [30, 31] , for example. Whether acute vs. chronic A 2A R activity induces opposing myocardial outcomes is unknown, though prolonged A 2B agonism limits rather than promotes fibrosis in injured myocardium [32] , as does prolonged A 1 agonism [33] .
Additional to questions regarding protective vs. deleterious effects of the A 2A R, the evolution of myocardial inflammatory injury and 'endotoxemic myocarditis' itself is complex and incompletely defined [1, 2] . Effects in non-cardiac tissues involve TLR/CD14-dependent NFκB and MAPK signalling and interferon/cytokine engagement of the JAK-STAT path [34] [35] [36] . These mechanisms likely participate in heart, with evidence NFκB and IκB kinase promotes cardiac dysfunction in sepsis/endotoxemia [37, 38] , while JAK-STAT signalling mediates dysfunction and cell death in myocardial ischemia [39, 40] . In vivo observations suggest marked expansion of this signalling in intact myocardium [41, 42] , contrasting in vitro evidence that cardiomyocyte NFκB and IκB kinase signalling is only transiently LPS responsive [43] . Importantly, these paths are inhibited by A 2A Rs in other cells, with exogenous agonism decreasing [44, 45] and A 2A R KO increasing NFκB activity [6] . Nonetheless, these paths can also promote myocardial stress-resistance and survival under conditions that include inflammatory cytokine challenge [46] [47] [48] . The molecular underpinnings of endotoxemic myocarditis in vivo warrant further investigation, as do the mechanisms countering this dysfunction (including A 2A R activity). We thus undertook broad-scale transcriptomic profiling of hearts from WT and A 2A R KO mice, at baseline and following endotoxin challenge: shifts in gene expression can shed light on both functions of the A 2A R, and pathogenesis and modulation of endotoxemic myocarditis. There are no prior analyses of transcriptome-wide effects of A 2A R activity in myocardium, and relatively few of the in situ cardiac response to endotoxemia or sepsis [41, 42, 49] .
Materials and methods

Animals
All animal procedures conformed to the Guide for the Care and Use of Laboratory Animals published by the NIH (publication number 85-25, revised 1996) . This project (and protocols for care of animals) was approved by the Animal Care and Use Committees of St. Jude Children's Research Hospital and the University of Tennessee Health Sciences Center. The A 2A R KO mice and WT littermates were obtained from a subcolony of the original lines generated and characterized by Ledent et al. [50] . Analysis of cardiac tissue confirms ablation of A 2A R transcript without compensatory shifts in other adenosine receptors (Fig. S1 ). Mice were bred and maintained onsite at St. Jude Children's Research Hospital, with standard laboratory food and water available ad libitum. Animal genotype was confirmed by PCR analysis of tail snips. All animals were originated from the same breeding series and were matched for age and weight. Male and female mice were used with equal representation in each experimental group. Both A 2A R KO and WT littermate mice were randomly allocated to receive either an intraperitoneal injection of 20 mg/kg LPS isolated from E. coli (Sigma-Aldrich, St. Louis, MO) or an equal volume of sterile saline vehicle. Blood was sampled at 12 and 24 h of LPS challenge to assess shifts in blood cell counts and circulating cytokines/biomarkers, as detailed by us previously [23] . Mice were monitored for the development of symptoms of illness or distress (lethargy, piloerection, hunched posture and/or respiratory distress) during the initial 12 h post-injection and every 4 h thereafter; observation of any combination of symptoms prompted immediate euthanasia. All efforts were made to minimize animal suffering and distress. No analgesic or anaesthetic was administered other than for euthanasia immediately on evidence of illness/ distress.
We initially tested responses to 24 h LPS challenge in both young (14 week) and old (46-52 weeks) WT and A 2A R KO mice. However, absent overt symptoms of illness/distress, there was nonetheless significant mortality in aged LPStreated mice, as detailed in the "Results" section and in Supplementary material. Cause of death in older animals was not determined. As a result of mortality, detailed molecular interrogation of cardiac gene expression (n = 6-8 per group), together with analyses of cardiac function in isolated hearts (n = 8-9 per group) and haematological/biomarker assessment (n = 6-9 per group) is necessarily constrained to the young group of mice.
Langendorff perfusion and tissue sampling
After 24 h of LPS challenge, mice were anaesthetised with sodium pentobarbital (50 mg/kg intraperitoneally), a thoracotomy performed and hearts excised into ice-cold KrebsHenseleit solution for Langendorff perfusion, as detailed previously [23] , or sampling of ventricular tissue for RNA preparation. Briefly, for perfusions, the aorta was immediately cannulated and hearts perfused at 80 mmHg with modified Krebs-Henseleit solution containing (in mM): NaCl, 120; NaHCO3, 25; KCl, 4.7; CaCl2, 2.5; MgCl2, 1.2; KH2PO4, 1.2; D-glucose, 15 and EDTA, 0.5. Perfusion fluid was maintained at 37°C and bubbled with a mix of 95 % O2/5 % CO2 at 37°C to provide a pH of 7.4. Ventricular function was monitored via a fluid-filled plastic film balloon in the left ventricle, connected to a P23 XL pressure transducer (ViggoSpectramed, Oxnard, CA, USA). Coronary flow was monitored via a flow-probe in the aortic perfusion line, connected to a T206 flowmeter (Transonic Systems Inc., Ithaca, NY, USA). Functional data were recorded at 1 KHz on MacLab data acquisition system (ADInstruments, Castle Hill, Australia). Statistical comparisons of cardiovascular (Table 1 ) and blood parameters ( Figs. 1 and 2 ) between groups were made via analysis of variance (ANOVA), with a Newman-Keuls post hoc test for specific comparisons. A P < 0.05 was considered indicative of significance in all tests.
RNA preparation and microarray hybridisation
Ventricular tissue was isolated, frozen in liquid N 2 and stored at −80°C until analysis. Tissue was subsequently homogenized in TRIzol reagent (Invitrogen, Carlsbad, CA) and total RNA isolated according to manufacturer's protocol. The RNA was further treated with 50 U of DNase I (Promega, Madison, WI) for 15 min at 37°C and purified on RNeasy spin columns (Qiagen, Hilden, Germany). Total RNA yield and integrity were determined spectrophotometrically and via capillary electrophoresis on a 2100 BioAnalyzer (Agilent, Palo Alto, CA), respectively.
Microarray experiments were performed at the St. Jude Hartwell Center Core Facility according to manufacturers' protocols. Briefly, first-and second-strand complementary DNA (cDNA) synthesis reactions were performed using the SuperScript Choice System (Invitrogen, Carlsbad, CA) followed by in vitro transcription using biotin-labelled dNTPs (ENZO Diagnostics, Farmingda le, NY). Complementary RNA (cRNA) samples were fragmented and individually hybridized to GeneChip® Mouse Genome 430 2.0 microarrays (Affymetrix, Santa Clara, CA). Each microarray quantified expression of over 39,000 transcripts, including full-length mRNA sequences and expressed sequence tags (ESTs). Following hybridization, microarrays were washed and stained with streptavidin-phycoerythrin (Molecular Probes, Eugene, OR) before scanning. Image files were converted into probe-set data (*.CEL files) via Affymetrix MAS 5.0 software. Experimental data are accessible through GEO Series accession number GSE44363 at http://www.ncbi.nlm.nih.gov/geo.
Microarray data and statistical analyses
Raw expression data were background corrected, normalized and log 2 transformed using the Robust Multichip Average (RMA) method in BioConductor/R [51] . Data were filtered to include only transcripts detected on ≥3 arrays, with 25,646 transcripts passing this quality criterion (i.e. consistently detected in cardiac tissue). Log 2 ratio values were generated by subtracting median expression values for WT vehicle-treated animals from each sample per probe before importing into TIGR MeV 4.0 software for statistical analysis [52] . The Significant Analysis of Microarrays (SAM) algorithm was used to correct for multiple comparisons and non-parametrically select differentially expressed genes using a median false discovery rate (FDR) ≤1.0 % [53] . In addition, a two-factor analysis of variance (ANOVA) was performed. To generate a data sets similar in size and false-positive rates, a P value <0.005 was employed. The lists of differentially expressed genes generated via SAM or ANOVA were then compared to identify 8110 shared transcripts for further investigation and validation (Fig. S2 ). This output was subjected to appropriate pair-wise SAM comparisons, incorporating a 1.5-fold change cut-off [54] . Significant transcripts were annotated using Ingenuity Pathway Analysis (IPA) (v8.7; Ingenuity® Systems, Redwood City, CA, USA), providing insight into biological/ molecular themes over-represented in response to A 2A R deletion and/or LPS. In brief, for each pathway/process, the fraction of differentially expressed genes was compared with the fraction of total genes in that path (shown in tables as the 'Ratio', useful for determining which pathways/processes overlap the most with altered genes in specific datasets). The probability of involvement of the respective number of modified transcripts in a path/process is expressed as a P value or range (values <0.05 considered significant).
Validation of expression changes and Adora expression via RT-qPCR
Two-step RT-qPCR, utilizing SYBR Green I, was employed to confirm differential gene expression for 11 transcripts (primer details provided in Table S1 ), as previously described [54] . Six additional genes (Actb, Gapdh, Hprt1, Pgk1, Ppia and Ubc) were assessed using GeNorm to determine utility as reference genes [55] . Following GeNorm assessment, Actb was found to be most stable (M = 0.03) and served as the endogenous reference control for all messenger RNAs (mRNAs) assessed via RT-qPCR. Briefly, 1 μg total RNA was used to synthesize cDNA using the Superscript III First-Strand Synthesis System (Invitrogen, Carlsbad, CA, USA) according to manufacturer's instructions. RT-qPCR was performed in a CFX96 Real-Time PCR Detection System (Bio-Rad, Hercules, CA). Final reaction volumes (10 μL) included 5 μL iQ SYBR-Green Supermix (BioRad, Hercules, CA), 100 nM of each primer and 4 μL of a 1:20 dilution of cDNA. Optimal qPCR cycling conditions entailed an initial denaturation at 95°C for 3 min followed by 40 cycles of 95°C for 15 s/62°C for 60 s. After the final PCR cycle, reactions underwent melt curve analysis to detect non-specific amplicons. All reactions were performed in triplicate, with each plate containing an equal number of samples from each group, a calibrator control derived from a pool of all cDNA samples and a notemplate control. PCR amplification efficiencies (90-110 %) for each primer pair were calculated using a 5-log serial dilution of calibrator sample. PCR data were analysed using CFX Manager v1.6 (Bio-Rad, Hercules, CA). Baseline subtractions and threshold settings above background were applied to all data. The calibrator sample was used to normalize inter-assay variations, with the threshold coefficient of variance for intra-and inter-assay replicates <1 % and <5 %, respectively. Normalized expression (ΔΔC q ) was calculated, with mRNAs normalized to Actb levels and the calibrator control then log 2 -transformed.
Results
Impact of A 2A AR deletion on cardiovascular function and inflammatory markers
Deletion of the A 2A R was confirmed in cardiac tissue, with no compensatory changes in transcription of the other three sub-types (Fig. S1 ). Receptor deletion did not modify cardiac or coronary function in healthy or endotoxemic hearts (Table 1) . Cardiovascular, blood cell and cytokine responses to LPS in WT and A 2A R KO mice have been reported by us previously [23] . Similar outcomes were apparent here for markers of inflammation and injury ( Fig. 1) , haematological parameters and cytokines ( Fig. 2 ) and cardiac function ( . There is thus a trend to greater mortality with age, with a major survival effect of A 2A R activity in older males. While molecular interrogations here are thus limited to young mice (in which LPS was non-lethal), it is possible A 2A R activity may be increasingly crucial to survival in older, stressintolerant males (whereas younger animals and females may possess intrinsically greater resistance to injury/death [57] ). This is discussed further in the online Supplementary material.
Cardiac transcriptomic response to A 2A R KO Few transcriptional differences were detected between WT and A 2A R KO hearts, with the amplitude of changes modest (up to threefold). Employing an initial 1.5-fold cut-off and 1 % FDR identified only 13 genes ( Table 2 ). To enhance the power of subsequent pathway analysis, these criteria were relaxed to 1.2-fold and 5 %, encompassing 37 altered transcripts ( Table 2 ). There was a little impact of A 2A R deletion on inflammatory mediators, with modest induction of a CXC chemokine (Ppbp, +2.1), a regulator of cell migration/adhesion and cytokinesis (Iqgap1, +1.6) and a hemopoietic cytokine (Tslp, +1.6), together with repression of Hp (−2.7) and an Ig adhesion molecule regulating T-lymphocyte development (Mpzl2, −1.7) ( Table 2) . Analysis via the IPA suite identified 112 canonical pathways sensitive to A 2A R activity in healthy hearts (Table S2) , the most highly modified shown in Table 3 . The top five included relaxin signalling, cardiac β-adrenergic signalling, cellular effects of sildenafil, PKA signalling and photo-transduction. The influence of A 2A R KO on these and other paths can be attributed to repression of Prkar2b (−1.8), Gnb1 (−1.7) and Pde3b (−1.7), collectively impacting G protein-coupled cAMP/PKA dependent signalling (encompassing relaxin, α-and β-adrenergic, NO, Ca 2+ and hypertrophic signalling). Additionally, Map3k2 (−2) and Nfat2c (+1.3) span many paths modified by A 2A R KO. Modulation of these five transcripts contributes to 48 of the top 50 A 2A R-sensitive canonical pathways. Overall, A 2A R deletion exerts an inhibitory effect on G protein-coupled, cAMP/PKA, and MEKK2 signalling downstream of this and other GPCRs.
Multiple biological functions appear sensitive to A 2A R KO (see Table S3 ), the most significant (Table 4) revolving around cellular development, growth, movement and death, together with humoral immunity and haematological development and intercellular signalling. Toxicological functions included high representation of liver processes (fibrosis, damage, steatosis, hepatitis and inflammation) together with six cardiac functions ( Table 4 ). The latter included cardiac arteriopathy (Ank3, Pon1, Cux2, Gk5, Pde3b, Dgat1 and Nsmce1), infarction (Pon1 and Acta1) and transcripts involved in failure and hypertrophy (Pde3b and Nfat2c).
Cardiac transcriptomic response to LPS
Analysis via the SAM algorithm (1.5-fold threshold, 1 % FDR) identified 4146 transcripts modified after 24 h of LPS challenge (see Table S4 for full details). Figure 3 Functional classifications, using a twofold threshold to narrow the focus to the most highly modified paths, identify 236 canonical pathways (Table S5) , with the most significantly modified presented in Table 5 . Data confirm a profound inflammatory and immune response, with marked upregulation of TLR/MyD88 and interferon signalling ( Additionally, LPS upregulated cell death signalling (Figs. S13 and S14) and modified paths involved in cellular differentiation, movement, growth and remodelling (e.g. Figs. S15 and S17). The top LPS-sensitive biological functions are summarized in Table S6 , with biologic and cardiovascular toxicological responses fully detailed in Table S7 and S8 in the Supplementary material. Unsurprisingly, many highly responsive transcripts were involved in inflammation (Figs. 3 and 4, Table 5 ): within the most induced are interferon-related genes (Ifit1, Ifit2, Ifit3, Igtp1, Igtp2, Igtp3, Iigp1, Iigp2, Ifi44 and Irf7) and inflammatory/immune modulators (Lcn2, Saa3, Socs3, S100a8, S100a9, Mpa2l, Cxcl1, Cxcl9, Cxcl10, IL6, Ptx3, Serpina3n, Csf3 and Mt2). Several are potentially injurious to the heart: the most highly induced transcript encodes lipocalin-2, which regulates inflammation and matrix degradation, is implicated in heart failure [58] and promotes cardiac apoptosis [59] ; CXCL1 is a potent neutrophil chemoattractant; CXCL9 stimulates cytokine production and T-cell proliferation/recruitment; CXCL10 mediates CXCR3 + cell migration and augments inflammation. Conversely, some transcripts encode anti-inflammatory and potentially protective molecules: SERPINA3N (α1-antichymotrypsin) inhibits proteases involved in inflammation; the pentraxin PTX3 is expressed in heart with inflammation and limits cell death; SOCS3 is a negative feedback regulator of IL-6 signalling, implicated in sex-dependent cardiac stress-resistance; metallothionein-2, induced by STAT3-related signalling, mediates cardioprotection and can limit dysfunction in sepsis.
Cardio-depressant molecular profile Major pathways critical to contractile function were substantially impacted, identifying a 'cardio-depressed' molecular profile in hearts of endotoxemic mice (Figs. S18-S21). β-A d r e ne rg i c s i g n al l i n g w a s b r oa d l y s u p pr e s s e d (Fig. S18 ), including reduced transcripts for β 1 -adrenergic receptor, G protein, adenylate cyclase, PKA and related signalling elements (Ppp1r14c, Gng11, Prkar2b, Pde7a, Ppp1r3c, Ppp1r14a, Pkia and Adcy7), together with induction of Pde4b (AMP-dependent phosphodiesterase). The PKA pathway itself was substantially suppressed (Fig. S19) , including reductions in PKA RIα (Prkar1a), PKA RIIα (Prkar2a), PKA RIIβ (Prkar2b), PKAα (Prkaca) and PKA-Cβ (Prkacb), while PKA RIβ (Prkar1b) was modestly induced (+1.5). Transcripts for G αs and G αq also declined. Cellular Ca 2+ signalling paths were repressed (Fig. S20) , with reductions in key elements including: Camk1d, Ryr3, Casq1, Mef2c, Casq2, Calm1, Hdac9, Myh7b, Tpm2, Myh11, Rcan1, Myl7, Atp2b2, Prkar2b, Tpm3 and Asph. Mitochondrial dysfunction (Fig. S21) is also evidenced by repression of complex I/NADH dehydrogenase components (including Ndufv2 and 3; Ndufs4, 5, 6, 7 and 8; Ndufa3, 4, 5, 6 and 8; Ndufab1, Ndufaf1, Ndufb2, 3, 4, 7, 9, 10 and 11), together with Complex II components (including Sdhc, Sdhd, Uqcrb, Uqcrc1 and Uqcrfs1). Uncoupling proteins Ucp2 and Ucp3 were also induced, while Ucp1 was repressed. Transcript for the major activator of mitochondrial biogenesis (Ppargc1a) was repressed.
Adenosine-related transcripts There were limited impacts on the adenosinergic system itself, with two-to threefold upregulation of adenosine deaminase, 1.5-fold repression of adenosine kinase, 1.7-fold induction of S-adenosylhomocysteine hydrolase and twofold induction of the ecto-nucleotidase CD39. These changes may modify patterns of cellular adenosine generation vs. uptake and metabolism, potentially altering receptor activation in endotoxemic tissue. A small 1.3-fold rise in Adora2b expression was also detected.
Impact of A 2A R KO on transcriptomic responses to endotoxemia
Interestingly, A 2A R activity does not broadly suppress the effects of endotoxemia on myocardial gene expression, with 90 % of transcriptomic responses unaltered by receptor KO. For example, Fig. 3 presents response profiles for the 25 most induced or repressed transcripts in WT hearts, with most shown to be insensitive to A 2A R KO. Deletion selectively enhanced induction of Lcn2, Igtp, Cxcl5, S100a8, Iigp2, Cxcl2 and Iigp1 and repression of C1qtnf9, Colec11 and Inmt, while reducing induction of Ifit3 and repression of Adipoq, Gpr22, and Scube2, Ifit3 (Fig. 3) . These effects support A 2A R modulation of inflammatory and interferon-related signalling responses. Nonetheless, the pattern of LPSdependent cytokine/chemokine change was largely insensitive to A 2A R KO, with specific enhancement of Cxcl5, Cxcl2, Il6 and Csf3 induction (Fig. 4) . Figure 6 summarizes the select effects of A 2A R activity (revealed via KO) on TLR-and interferon-triggered NFκB and JAK-STAT signalling responses to LPS (generally repressing these pathways).
To gain further insight into these specific effects of A 2A R KO, we identified those LPS-responsive transcripts whose expression changes were increased or reduced ≥1.5-fold by A 2A R KO (Table S9 ). Effects of LPS on 282 genes were augmented ≥1.5-fold following A 2A R KO, with a further 9 responsive to LPS specifically in KO and not WT hearts (Table S9 ). The most highly augmented included 25 transcripts increased ≥twofold by KO. Many A 2A R-sensitive transcripts are associated with pro-inflammatory signalling (e.g. Igtp, Lcn2, Cxcl5, S100a8, Iigp2, Cxcl2, Il6, Ifi202b, Hp and Cxcl9), with data supporting inhibitory effects of the A 2A R on the responsiveness of canonical pathways that include the acute phase response, glucocorticoid receptor, Erk/MAPK, HIF1α and JAK-STAT signalling (Table 6) .
Deletion of the A 2A R reduced or entirely eliminated 134 gene responses to LPS (Table S9 ). Responses entirely A 2A Rdependent included repression of Sacs, Cidec, Gnb1l, Mtap1b, Msi2, Cdh2, Lpgat1, Tbx3, Slc38a1, Sdc1, Reln, Ext1 and Pvrl3, and induction of Rit1, Ezh1, Eif4ebp1 and Abhd4 (Table S9 ). The transcripts most sensitive to A 2A R KO included Dnmt3a, Qk, Sema5a, Srpk2, Car3, Ucp1, Rsad2 and Dnajb14. Highly LPS-responsive changes counteracted by A 2A R KO included: Ifit3, Rsad2, Cxcl13, Ms4a6d, Oasl1, Ms4a4c, Sema5a, Tyki and Hmox1. Intrinsic A 2A R activity thus also promotes LPS-dependent shifts in select genes associated with immune/inflammatory processes, including orphan nuclear receptor and PPARα activation, PRR responses to infection, AMPK signalling and NFκB signalling (Table 6 ).
In terms of biological functions, A 2A R activity reduced LPS responsiveness of paths related to cellular movement, growth, signalling and death, immune cell trafficking and haematological and cardiovascular development (Tables 7  and S10 ). Conversely, A 2A R activity appears to augment responses in pathways related to metabolism and transport, together with organ, haematological, cardiovascular and lymphoid development (Table 7) , with complete details of pathway responses modified by A 2A R KO included in Table S10 . Deletion of the A 2A R also influenced multiple toxicological functions; of 35 responses countered by A 2A R KO, 12 were cardiac-specific categories (Table S11) Tables 6 and S10 ). These data point to an influence of intrinsic A 2A R activity on key signalling responses, including G protein, PKA, S TAT 1 a n d N F κ B -d e p e n d e n t p r o c e s s e s ( s e e Supplementary material for additional discussion). While the absence of A 2A Rs impacted inflammatory and underlying signalling changes in endotoxemia, paths implicated in endotoxemic cardio-depression (ß-adrenergic and PKA signalling, Ca 2+ handling, excitation-contraction coupling and mitochondrial function; Figs. S18-S21) were not among those sensitive to A 2A R KO (Table 6) , consistent with a lack of effect of A 2A R KO on contractile dysfunction itself (Table 1) .
PCR analysis of select transcripts
Quantitative RT-PCR analysis supports microarraydetermined changes in transcripts selected for differential responsiveness to LPS and A 2A R KO (Fig. 7) . While expression ratios vary slightly between the two methods, a significant linear relationship was apparent between both measures (with a slope > 1 suggesting greater dynamic range for RT-qPCR measurement).
Discussion
The present study characterizes impacts of A 2A R deletion on the myocardial transcriptome, markers of inflammation and cardiac function and injury in healthy and endotoxemic mice. Data indicate A 2A R activity exerts limited effects in un-stressed myocardium, with t r a n s c r i p t o m i c c h a n g e s l i m i t e d t o G p r o t e i n , cAMP/PKA and cGMP/NO signalling downstream of this and other GPCRs (Tables 2 and 3 ). However, during endotoxemia, absence of A 2A Rs exaggerated myocardial injury (and age-and sex-dependent mortality), without substantially modifying patterns of cytokine release, myocardial cytokine/chemokine transcription or contractile depression. The latter is consistent with insensitivity of the 'cardio-depressant' profile in endotoxemic hearts to A 2A R KO. Rather, data reveal A 2A R activity selectively influences transcription of regulators of NFκB and JAK-STAT signalling during endotoxemia, which may limit myocardial inflammation (Tables 3 and  S2) , involved in cellular growth/movement/death, immune and cell-to-cell signalling, and toxicological processes of fibrosis, cell damage and inflammation. This profile stems from a handful of changes spanning pathways (i.e. Gnb1, Nfat2c, Acta1, Prkar2b, Map3k2 and Pde3b), supporting effects of A 2A R activity on G protein and cAMP/PKA signalling downstream of the receptor [5, 8, 60] . Deletion of the A 2A R has been shown to reduce cAMP and PKA activation in other cell types [61] , consistent with impacts of KO here ( Table 3 ). The altered MEKK2 path is also linked to G protein/Rac-dependent signalling distal to this and other GPCRs. In terms of vasoregulatory functions of the A 2A R, shifts in inter-related pathways involved in relaxin signalling, cellular effects of sildenafil and NO signalling ( Table 3 ) support modulation of cGMP/NOS dependent control, while cardiac arteriopathy was identified as a pathologic process sensitive to A 2A R KO (Table 4) . These rather limited transcriptomic changes in healthy myocardium are consistent with observations in other tissues. For example, Yu et al. [62] found A 2A R KO alters a very small sub-set of transcripts in healthy striatum (implicating A 2A R sensitive EGR-2 control), with expression changes also modest (a majority ≤twofold). Others report no impact of A 2A R KO on myocardial expression of RAC1, ERK1/2, p38-MAPK or JNK [14] , though phospho-activation of the latter kinases was impaired, potentially reflecting shifts in cAMP/PKA and MEKK2 signalling.
Transcriptomic profile of endotoxemic myocardium
Myocardial injury and dysfunction are critical determinants of circulatory changes and mortality with uncontrolled inflammation; however, their mechanistic basis is poorly defined. Transcriptomic interrogation can reveal elements of these complex responses, though there are f e w a n a l y s e s o f m y o c a r d i a l [ 4 1 , 4 2 , 4 9 ] or cardiomyocyte [43, 49] responses to endotoxin/sepsis. Approximately 15 % of the 25,646 transcripts expressed in murine hearts were modified in endotoxemia (Table S4) , encompassing a multiplicity of canonical paths and functions (Tables 5, S5-S7) . Many are consistent with those highlighted by Wong et al. in more limited analysis of endotoxemic rats [41] and Rudiger et al. in a rat faecal peritonitis model [49] . The myocardial response involves profound upregulation of immune/inflammatory paths (Figs. 3-5 and S4-S7) , the most highly modified including acute-phase response, PRR/TLR and interferon/IRF signalling (Table 5) . Underlying NFκB, JAK-STAT and MAPK/PI3K paths are up-regulated (Tables 5, S5 and S7; Figs. S8-S12), with NFκB/JAK-STAT mechanistically linking the top five canonical pathway responses. Integrated signalling via NFκB and JAK-STAT paths thus appears central to myocardial endotoxemia, as in other tissues. In other tissues, these paths are also targeted by A 2A Rs to suppress inflammatory/immune responses [44, 45, 58] , with KO augmenting NFκB activation in macrophages, for example [6] .
Amplified cardiac TLR and interferon signalling Since uncontrolled inflammation induces cellular injury/death, pro-inflammatory TLR/CD14 signalling is the subject to negative control. However, this path was transcriptionally amplified in endotoxemic myocardium (Fig. 5) , including receptor molecules (Cd14, Tlr1, Tlr2, Tlr3 and Tlr4) and LPS-binding protein (Lbp), transduction molecules (Cr3/Mac1 and Cr4), MyD88, TIRAP and MyD88 targets (Il6 and Il1b), MyD88-independent signal components (Tbk1, Cxcl10, Ccl2 and Ccl5) and d o w n s t r e a m J A K -S TAT s i g n a l l i n g ( F i g . S 9 ) . Upregulated TLR and MyD88-dependent and independent signalling are consistent with changes in rat sepsis [49] , though Tlr4, Cd14 and Tirap induction here was not apparent in the rat model. Sweeney et al. [63] recently reported a novel MyD88-independent path linking TLR2/TLR4 signalling to Ppargc1a, encoding the mitochondrial biogenesis co-regulator PGC-1α. However, despite induction of elements of this path here (including Tlr2, Tlr3, Tlr4 and Irf7), cardiac Ppargc1a was repressed by LPS, a response potentially exaggerating mitochondrial dysfunction and countered by A 2A R activity.
Interferon signalling transducing inflammatory/TLR responses was also upregulated (Fig. 5) , including a majority of gene targets and the path of IRF activation by PRRs (Figs. S5-S7 ). This entailed induction of membrane (Tlr2, Tlr3 and Tlr4), cytosolic (Ddx58, Ifih1, Eif2ak2 and Oas1) and extracellular (C1q, C3, C3a and Ptx3) receptors, and downstream mediators (Il6, Irf7 and Rantes). These shifts in TLR/CD14, MyD88-dependent and -independent and interferon/IRF signalling are relevant to temporal expansion of molecular changes [41, 42] and injury progression in [67] , inflammation and injury [68, 69] . These profound responses diverge from in vitro data suggesting dampened/transient impacts of LPS on isolated myocyte NFκB and IκB kinase [43, 63] .
Endotoxemic cardio-depression Cardiomyocyte and myocardial function is LPS-sensitive and depressed in endotoxemia [21, 23, 70, 71] (Table 1 ). This has been linked to abnormalities in myofibrillar Ca 2+ sensitivity [70, 71] , adrenergic control [71] [72] [73] [74] and mitochondrial function [75] , together with cell death [23, 76, 77] . Transient changes in preload may also mediate early reversible depression in vivo [78] . Transcriptomic data reveal a cardio-depressant profile entailing suppression of key determinants of contraction, including Ca 2+ , β-adrenergic and PKA signalling, mitochondrial function and electromechanical coupling (Figs. S18-S21) . Importantly, and despite other impacts, A 2A R expression did not influence this cardio-depressant profile nor modify contractile depression (Table 1) [23] .
Suppression of β-adrenergic and Ca 2+ signalling is consistent with desensitization in hearts and myocytes [71] [72] [73] , and transcriptional changes in a rat model of faecal peritonitis [49] . Despite overlap with the latter response, the β 1 -rather than β 2 -adrenoceptor is depressed in endotoxemic mouse heart (Fig. S18) , while reductions in AKAP, PP1, PP2A, NCX and L-type Ca 2+ channel components observed here were not evident in the peritonitis model. Nonetheless, data collectively implicate β-adrenergic dysfunction as a common component of cardio-depression, consistent with reductions observed in β-adrenoceptor expression [73] , tissue noradrenaline and adrenaline [73] and adrenoceptor stimulation of cAMP and Ca 2+ fluxes [73] . In terms of approaches to inotropic support, coincident depression of adrenoceptor, PKA and Ca 2+ signalling may limit the value of interventions targeting these effectors. Abnormalities within the contractile apparatus itself (repressed α-tropomyosin, troponin-T, α-actin and titin transcription) may also be relevant. Targeting mitochondrial dysfunction may more broadly improve cardiac outcomes: repression of Complex I components (Fig. S21) is consistent with Complex I specific dysfunction and ROS generation in mitochondria from endotoxemic hearts [75, 79] .
Additional cardio-depressant changes include altered TLR4 and fibroblast factor signalling, suppression of substrate metabolism and IGF-1 signalling (Fig. S22) and induction of inhibitory S100a8/S100a9, Icam1, Vcam1, Cybb (NOX2), Ptgs2 (COX2) and the TNF-α receptors Tnfr1 and Fas. Marked induction of S100 A8 and S100 A9 (TLR4 activators promoting endotoxemic injury) has been observed in LPS-treated myocytes, involving MyD88 and NFκB signalling [80] . Intriguingly, two adipokines with opposing actions, relevant to cardiac dysfunction, were among the most responsive to LPS. Pro-inflammatory and injurious lipocalin-2 (Lcn2) was the most induced (~600-fold), consistent with changes in rodent and human myocarditis [59] , while anti-inflammatory and cardioprotective adiponectin (Adipoq) was the second most repressed. Lipocalin-2 is induced via IκBζ (+13 with LPS) and with heart failure, ischemia and inflammation [81, 82] . Profound induction may promote dysfunction given its inflammatory [83] , pro-death [82, 84] and mitochondrial actions [84] . Current data suggest the A 2A R may beneficially limit LPS-dependent IκBζ induction to suppress injurious lipocalin-2. Highly repressed adiponectin exerts anti-inflammatory, anti-oxidant and cardioprotective effects [85, 86] , thus downregulation is also likely to promote inflammation and sensitize myocardium to oxidativestress and cell death. Curiously, Adipoq repression was reduced with A 2A R KO, suggesting a positive influence of A 2A R activity on this response. These and other changes relevant to pathogenesis of cardiac depression Dendritic cell maturation 9.12E-07
1.51E-01
B2m, Rac2, Icam1, Lepr, Nfkbie, Pik3r5, Cd83, Il6, Jak2, Fcgr2b, Fcgr1a, Nfkbia, Hlab, Tlr3, Stat1, Nfkbib, Fcgr3a, Hla-c, Myd88, Tnfrsf1a, Relb, Rac1, Nfkb2, Tlr2, Il1rn, Fcer1g, Stat2, Irf8 Role of macrophages, fibroblasts and endothelial cells in rheumatoid arthritis 2.57E-06
1.34E-01
Socs3, Rac2, Icam1, Mmp3, Nfkbie, Pik3r5, Jak2, Ccl5, Il6, Il17ra, Fcgr1a, Pgf, Myc, C1r, Il1r2, Vegfa, Nfkbia, Traf3Ip2, Wif1, Cfb, Plcb1, Tlr3, Nfkbib, Prkd1, Fcgr3a, Calm1, Adamts4, Sele, Vcam1, Myd88, Tnfrsf1a, C1s, Daam1, Rac1, Vegfc, Stat3, Cebpb, Irak3, Tlr2, Hp, Rras2, Il1Rn, Csf1, Cxcl12, Cebpd, Sost, Wnt5a, Irak2
Retinoic acid mediated apoptosis signalling 5.37E-06
1.94E-01
Parp10, Art1, Tnfsf10, Parp3, Parp12, Parp9, Tiparp, Irf1, Parp4, Bid, Parp11, Cflar, Parp14 Antigen presentation pathway 6.61E-06
2.56E-01
B2m, Psmb9, Hla-e, Hla-b, Psmb8, Hla-g, Tap1, Tap2, Tapbp, Hla-c
Role of pattern recognition receptors in recognition of bacteria and viruses
8.32E-06 2.12E-01
Ptx3, Oas1, C3, Oas2, Myd88, Pik3R5, Il6, Nfkb2, Ccl5, Tlr2, Ifih1, Clec7a, Irf7, Syk, Ddx58, Eif2ak2, Tlr3 Death receptor signalling 1.29E-05
2.34E-01
Hspb3, Tnfrsf1a, Nfkbie, Tnfsf10, Tbk1, Nfkb2, Fas, Daxx, Nfkbia, Bid, Cflar, Nfkbib, Birc3, Birc2, Hspb1 IL-10 signalling 3.24E-05
2.14E-01
Ccr1, Socs3, Il4r, Nfkbie, Il6, Stat3, Nfkb2, Fcgr2b, Il1r2, Hmox1, Nfkbia, Il1rn, Cd14, Lbp, Nfkbib Role of RIG1-like receptors in antiviral innate immunity 6.61E-05
1.96E-01
Dhx58, Ifih1, Irf7, Nfkbia, Nfkbie, Ddx58, Tbk1, Nfkb2, Nfkbib, Trim25
IL-6 signalling 1.00E-04
1.94E-01
Hspb3, Tnfrsf1a, Nfkbie, Il6, Nfkb2, Stat3, Cebpb, Jak2, Il1r2, Shc1, Nfkbia, Rras2, Il1rn, Cd14, Lbp, Nfkbib, Tnfaip6, Hspb1 IL-8 signalling 1.02E-04
1.45E-01
Rac2, Icam1, Cxcl1, Pik3r5, Pgf, Eif4ebp1, Vegfa, Hmox1, Gng11, Gna13, Nfkbib, Prkd1, Egfr, Vcam1, Rhoc, Rac1, Vegfc, Irak3, Cstb, Myl7, Myl9 (Includes Eg:98,932), Bcl2l1, Itgb2, Rras2, Ccnd2, Itgam, Irak2 Bladder cancer signalling 1.26E-04
1.89E-01
Fgf16, Mmp3, Fgf9, Mmp14, Mmp15, Vegfc, Pgf, Myc, Vegfa, Rras2, Mmp8, Fgf12, Cdkn1a, Chd1 (Includes Eg:1105), Rps6Ka5, Fgf7, Egfr Pathogenesis of multiple sclerosis 1.45E-04
5.56E-01
Cxcl10, Ccr1, Cxcl9, Ccl5, Cxcl11
Role of PKR in interferon induction and antiviral response 1.58E-04
2.39E-01
Nfkbia, Tnfrsf1a, Nfkbie, Bid, Nfkb2, Eif2ak2, Tlr3, Stat1, Nfkbib, Fcgr1a, Irf1
JAK/Stat signalling 2.00E-04
2.19E-01
Rac2, Socs3, Pias2, Socs2, Rac1, Pik3r5, Stat3, Jak2, Shc1, Rras2, Cdkn1a, Cish, Stat2, Stat1 Complement system 2.09E-04
2.5E-01
C1R, Cfd, Serping1, C3, C1S, Cfb, C4a, Masp1, C2
Glucocorticoid receptor signalling 2.14E-04
1.25E-01
Rac2, Icam1, Nfkbie, Pik3R5, Pbx1, Ccl5, Jak2, Il6, Fcgr1a, Nr3c1, Il1R2, Shc1, Cxcl3, Hspa4, Nfkbia, Ar, Ccl13, Cdkn1c, Serpine1, Stat1, Fkbp5, Nfkbib, Sra1, Vcam1, Ccnh, Sele, Rac1, Stat3, Cebpb, Bcl2l1, Rras2, Il1rn, Cdkn1a, Fkbp4, Nr3c2
are discussed further in the online Supplementary material.
A 2A R modulation of the endotoxemic transcriptome
Despite well-established anti-inflammatory effects of acute A 2A R agonism, the myocardial transcriptomic response to endotoxemia was largely insensitive to A 2A R KO ( Figs. 3 and 4 ; Tables 7 and S9 ). Rather than a broadly suppressive impact of A 2A R activity, only 10 % of the transcriptomic response was modified by KO. This selective outcome is consistent with data for cytokine/chemokine transcription and release-the majority of these responses were also unaltered by A 2A R deletion, which specifically modified Il6, Cxcl2, Cxcl5 and Csf3 induction (Fig. 4) and circulating IL-5, haptoglobin and CRP levels ( Figs. 1 and 2 ). These responses are nonetheless relevant to myocardial outcome: IL-6 initiates and expands inflammatory signalling, and CXCL2 and CXCL5 both participate in cardiac inflammation and remodelling. Important IL-6 target genes were highly induced with LPS, including Bcl2l1, Cebpb, Irf1, JunB, Lbp, Socs3 and Timp1. By suppressing IL-6 transcription, potentially through IκBζ induction and STAT1 repression, A 2A R activity may limit cardiac IL-6 signalling. Functional annotation of A 2A R sensitive transcripts does support modulation of acute phase response, JAK-STAT, MAPK, PRR and NFκB pathways (Tables 7, S6 and S10). Figure 6 summarizes these key changes, highlighting impacts of A 2A R KO. Through modifying a small number of key transcript responses (Nfkbie, Nfkbiz, Il6, Lcn2, Stat1, Cdkn1a and Rras2), A 2A R activity may limit expansion of injurious inflammation in endotoxemic myocardium. In contrast, the cardio-depressant molecular profile appears insensitive to A 2A R KO.
NFκB signalling The A 2A R represses NFκB signalling via multiple mechanisms in non-cardiac cells, including phosphorylation-/SUMOylation-dependent IκB degradation and modulation of the SCF-E3 ubiquitin ligase complex [58] . The absence of A 2A Rs did modify the NFκB path in endotoxemic myocardium (Fig. 6) , amplifying proinflammatory Nfkbiz (IκBζ) induction while countering inhibitory Nfkbie (IκBε) induction. Enhanced transcription of IκBζ and its targets Lcn2 and Il6 with A 2A R KO suggests the receptor may suppress inflammation by inhibiting IκBζ induction and its transcriptional actions, while promoting IκBε induction to limit nuclear translocation of NFκB (Fig. 6) . In contrast, A 2A R KO also reduced induction of molecules promoting NFκB signalling (Fig. 6 ): Eif2ak2/Pkr inhibits IκBα expression and enhances NFκB signaling and IFN-β expression; Btrc promotes degradation of IκBα and Rac2 promotes cytokine-triggered NFκB signalling and IFN-γ expression. It is unclear what the balance of these changes might be, though repression Glucocorticoid receptor signalling 9.33E-04
3.90E-02
Hspa4, Cxcl3, Rras2, Pik3r1, Cdkn1a, Tgfb2, Il6, Stat1, Serpine1, Hspa2, Nr3c1 Glioma invasiveness signalling 1.29E-03
8.47E-02
Timp4, Rras2, Pik3r1, Rhoj, Itgb3
Germ cell-sertoli cell junction signalling 1.45E-03
5.00E-02
Rras2, Tuba8, Pak6, Map3k6, Pak3, Pik3r1, Tgfb2, Rhoj
Angiopoietin signalling 3.16E-03
6.58E-02
Grb14, Rras2, Pak6, Pak3, Pik3r1
ILK signalling 3.55E-03
4.26E-02
Ppp2r3a, Pik3r1, Vegfc, Atf4, Rhoj, Itgb6, Pgf, Itgb3
Ephrin receptor signalling 3.98E-03
4.04E-02
Rras2, Pak6, Pak3, Vegfc, Atf4, Epha4, Efnb3, Pgf ERK/MAPK signalling 4.37E-03
4.10E-02
Rras2, Pak6, Pak3, Ppp2r3a, Ppp1R3c, Pik3r1, Atf4, Stat1
Pancreatic adenocarcinoma signalling 4.47E-03
5.08E-02
Pik3r1, Cdkn1a, Tgfb2, Vegfc, Stat1, Pgf HER-2 signalling in breast cancer 5.13E-03
6.17E-02
Rras2, Pik3r1, Cdkn1a, Itgb6, Itgb3
Macrophage NO & ROS production 7.08E-03
3.74E-02
Map3k6, Ppp2r3a, Ppp1r3c, Pik3r1, Rhoj, Irf8, Stat1
Hepatic fibrosis/stellate cell activation 1.05E-02
4.48E-02
Cxcl3, Tgfb2, Vegfc, Il6, Stat1, Pgf
Circadian rhythm signalling 1.12E-02
8.57E-02
Per3, Arntl, Atf4 Nicotinate and nicotinamide metabolism 3.98E-03
2.94E-02
Cilp, Art5, Eif2ak2, Bst1
Amyloid processing 4.57E-03
5.08E-02
Rac2, Prkar2b, Capn10
Glutamate receptor signalling 5.89E-03
4.29E-02
Glul, Slc38a1, Homer1 AMPK signalling 9.55E-03
2.40E-02
Rac2, Prkar2b, Adipoq, Eif4ebp1
PRRs in recognition of bacteria & viruses 9.77E-03
3.66E-02
C3, Ddx58, Eif2ak2
NF-κB signalling 1.15E-02
2.58E-02
Rac2, Nfkbie, Btrc, Eif2ak2
NF-κB activation by viruses 1.23E-02
3.61E-02
Rac2, Nfkbie, Eif2ak2
Inhibition of angiogenesis by TSP1 1.55E-02
5.56E-02
Rac2, Sdc1
Role of RIG1-like receptors in antiviral innate immunity 1.66E-02
3.92E-02
Nfkbie, Ddx58
FXR/RXR activation 1.78E-02
2.91E-02
TR/RXR activation 1.78E-02
3.03E-02
Rac2, Ucp1
PPARα/RXRα activation 1.86E-02
2.22E-02
Prkar2b, Nfkbie, Adipoq RANK signalling in osteoclasts 1.95E-02
3.06E-02
Rac2, Nfkbie, Map3k2
Fcγ receptor-mediated phagocytosis in macrophages and monocytes 2.04E-02
2.97E-02
Hmox1, Rac2, Hck
Canonical pathways modified by LPS, ranked according to P-values determined by Fisher's Exact Test. Also shown is the ratio reflecting the number of molecules in a given path that meet cut-off criteria for differential expression, divided by the total number of molecules in the path of the distal transcriptional effector IκBζ is predicted to limit effects of up-stream changes. Failure of A 2A R KO to modify changes in genes recently implicated in cardioprotective effects of NFκB signalling [47] (including induction of Ptx3, Plscr1, Sfi1 and Igfbp3 and repression of Car3, Dkk3, ai605517 and Grhl2) suggests receptor activity might selectively modify injurious rather than protective aspects of NFκB signalling.
JAK-STAT signalling
In non-cardiac cells, A 2A R agonism also inhibits JAK-STAT signalling, via control of SOCS transcription [58] and ubiquitination/degradation of JAK- Disruption of insulin-dependent glucose metabolism is an important consequence of endotoxemia, and three of the most A 2A R-sensitive transcripts (Ptprf, Glut4/Slc2a4 and Glut12/ Slc2a12) govern insulin-dependent glucose uptake (Table S9 ). Endotoxemic suppression of Glut4 and the secondary insulin-sensitive transporter Glut12 and the induction of Ptprf (encoding protein tyrosine phosphatase, receptor type F; implicated in insulin-resistance) were exaggerated >two-fold with A 2A R KO (Table S9 ). Endotoxemic suppression of Glut4 and glucose uptake is reported in skeletal and cardiac muscle [89] . Conversely, increased expression of Glut4 improves glucose uptake and limits myocardial dysfunction in endotoxemia [89] . These responses to A 2A R KO suggest regulatory influences of A 2A R activity on glucose handling in endotoxemic tissue.
Other highly A 2A R-sensitive transcriptional responses suggest A 2A R modulation of myocardial remodelling, including shifts in Asb14 and Asb15, Ca3 and Ca4 and Dnmt3a and Srpk2. Endotoxemic repression of transcripts for 2 ankyrin repeat and SOCS box (ASB) proteins, Asb14 and Asb15, was substantially exaggerated with A 2A R KO. The ASB family bind and target proteins for degradation and regulate skeletal muscle development, while roles in heart are unclear. The ASB15 protein enhances skeletal muscle protein synthesis [90] and delays differentiation, potentially via modulating MAPK and PI3K/Akt signalling [91] . This control may be important in adaptive response to muscle load/activity. Carbonic anhydrases are also implicated in myocardial hypertrophy, with endotoxemic Car4 induction (the dominant cardiac isoform) exaggerated and Car3 downregulation was inhibited in A 2A R KO hearts. The myocardial roles of these enzymes are only beginning to be unravelled, though they may promote hypertrophic responses by facilitating Na + -H + and Cl-HCO 3 exchanger over-activities, while evidence from other cells suggests CAR3 may modify oxidative stress and apoptosis. Similarly, Srpk2 induction was augmented in the absence of A 2A Rs, encoding a serine/arginine (SR) protein kinase (SRPK) that phosphory l a t e s S R d o m a i n -c o n t a i n i n g p r o t e i n s w i t h i n interchromatin granule clusters/nuclear speckles to regulate pre-mRNA splicing. The SRPK2 protein also plays an important role in cell proliferation and apoptosis. Additionally, downregulation of the methyltransferase transcript Dnmt3a, governing growth and function of embryonic myocytes [92] , appears to be countered by A 2A R activity, which may also limit cardiac fibrosis/remodelling [93] . Collectively, this suite of A 2A R responsive changes may limit myocardial hypertrophy and remodelling responses to inflammatory insult. This is consistent with functional groupings sensitive to A 2A R KO, including determinants of cell cycle, growth, proliferation and death and cardiovascular development (Table 7) and shifts in canonical hypertrophy pathways (Tables S10 and S11) .
Curiously, A 2A R activity also limited LPS induction of Hcn1 (Table S9 ). The HCN proteins mediate the pacemaker (funny) current governing cardiac automaticity/excitability. While HCN4 is the most highly expressed, HCN1 is significantly expressed within the conduction network, contributes to cardiac rhythmicity [94] and is up-regulated in hypertrophy and heart failure. Endotoxemic induction may thus promote arrhythmicity, while A 2A R activity appears to suppress this change.
Finally, A 2A R KO modified a broader range of vascular control and growth pathways in endotoxemic (vs. healthy) hearts. Vascular dysfunction is a critical to organ damage and mortality and may involve NOS overactivity in some vascular beds. Deletion of the A 2A R modified NO signalling together with renin-angiotensin signalling (Table S10) , while cardiac arteriopathy was identified as a pathological process sensitive to KO (Table S11 ). These responses support influences of A 2A R signalling on vascular pathology. We have previously shown endotoxemia impairs coronary hyperaemia, a dysfunction mimicked by KO of (and potentially involving) the A 2A R [23] . Additionally, there is an apparent coronary 'over-supply' relative to myocardial demand in endotoxemic hearts (Table 1) , owing to 25-30 % lower contractile function without reductions in coronary perfusion. The absence of coronary coupling to ventricular activity, described by us in this and other models [95, 96] , suggests additional coronary dysregulation (though this effect is neither replicated nor modified by A 2A R KO). Multiple paths/mediators regulating angiogenesis were also sensitive to A 2A R KO in endotoxemic heart, including shifts in VEGF, HIF-1α, angiopoietin, TGF-β, GM-CSF, PDGF and IGF-1 pathways (Table S10 ) and key regulatory molecules (including exaggerated induction of Il6, Pgf, Tgfb2, Tgfb2r, Angptl4 and Amotl1; exaggerated suppression of Vegfc and reduced suppression of Qk) (Table S9 ). While the A 2B receptor is more broadly implicated in control of angiogenesis, these changes suggest A 2A R-dependent processes may influence angiogenesis in the context of uncontrolled inflammation.
RT-qPCR confirmation of microarray-detected responses
Data confirm agreement between transcript expression determined via RT-qPCR and microarray methods (Fig. 7) , with PCR further highlighting distinct transcriptional effects of A 2A R KO: in some cases, KO eliminates responses to LPS (Acta1); alters baseline yet not LPSdependent expression (Amid or Dbp); enhances induction (Txnip) or repression (Cidec) in response to vehicle and LPS or reduces gene expression in the vehicle group while negating further changes with LPS (Eif4ebp2 and Slc38a1). Confirming the microarray approach, some of these responses are also functionally relevant. For example, Txnip encodes a stress-responsive protein inhibiting the anti-oxidant/signalling molecule thioredoxin. Reductions in TXNIP inhibit vascular inflammation and TNF-α signalling [97] , TXNIP dysregulation promotes inflammatory disease [98] and elevations in TXNIP facilitate apoptosis [99] . Inhibition of Txnip induction by A 2A R activity may thus enhance protective thioredoxin functionality.
Study limitations
Several study limitations are worth noting. While essential genesis of cardiac injury is studied and understood within the in situ organ, this entails experimental limitations inherent to in vivo studies of organ dysfunction in sepsis/ endotoxemia [15, 16, 20, 21, 24, 41, 42, 49] . Organ injury in these settings not only involves intrinsic organ-specific mechanisms but also influenced by extrinsic factors, including shifts in systemic inflammation, haemodynamics and neuroendocrine influences (with relative impacts of these factors difficult to delineate). Although we assess the intrinsic myocardial dysfunction in ex vivo tissue (together with in vivo markers of cardiac damage), we cannot isolate potential influences of A 2A R KO on cardiac loading, neurohumoral factors or indeed systemic inflammation. That said, while A 2A R KO augmented some inflammatory markers, systemic and cardiac cytokine responses were largely insensitive to KO and the myocardial response was very selectively modified, indicating distinct effects of A 2A R activity on cardiac injury processes. We are also unable to detail cell-specific origins of myocardial transcriptional changes. Migrating inflammatory cells could influence the transcriptomic profile for intact myocardium, though, as detailed in the Supplementary material, the expression profile of endotoxemic myocardial tissue is inconsistent with major contamination from such cells. An added limitation relates to the intriguing observation of both age-and sex-dependent mortality effects of LPS and A 2A Rs (Fig. S3) . This unfortunately precluded any detailed interrogation of these outcomes due to poor survival in older KO mice. Future work might focus specifically on responses to LPS/sepsis in clinically relevant aged cohorts, correlating age-dependent transcriptomic and phenotypic outcomes. Finally, while profound transcriptional changes observed in the current profiling study are predicted to translate to functionally relevant protein changes, this exploratory analysis does not directly confirm altered protein expression.
Conclusions
Deletion of the A 2A R induces modest effects in healthy myocardium, shifting transcription of G protein coupled cAMP/PKA, MEKK2 and cGMP/NO signalling downstream of this and other GPCRs, without impacting cardiac function. However, the receptor may play a retaliatory role in selectively suppressing inflammatory signalling and injury, yet, not contractile depression, in endotoxemic myocardium. Cardiac endotoxemia itself is characterized by profound upregulation of acute-phase response, PRR/TLR and interferon signalling and cell death and remodelling pathways, together with broad suppression of primary determinants of contractility (Ca 2+ , ß-adrenergic and PKA signalling; mitochondrial function; electromechanical coupling) and induction of cardio-depressant genes (Lcn2, S100a8/S100a9, Icam1, Vcam1, Nox2, Cox2, Tnfr1 and Fas). This complex transcriptome is selectively A 2A R sensitive, with effects of KO implicating modulation of key regulatory molecules (Nfkbie, Nfkbiz, Il6, Lcn2, Stat1, Cdkn1a and Rras2) to suppress myocardial JAK-STAT/NFκB and pro-inflammatory IL-6 and TLR signalling, together with influencing determinants of insulin-sensitivity, hypertrophy/remodelling and vascular function/angiogenesis. In contrast, endotoxemic suppression of β-adrenergic, PKA, Ca 2+ signalling, electromechanical and mitochondrial function pathways appears insensitive to A 2A R KO, as does contractile dysfunction itself.
